SLCO1A2
Solute carrier organic anion transporter family member 1A2
Also known as: OATP, OATP-A, OATP1A2, SLC21A3, SO1A2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46721
- Gene
- SLCO1A2
- Ensembl
- ENSG00000084453
- Chromosome
- 12
- Canonical length
- 670 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a sodium-independent transporter which mediates cellular uptake of organic ions in the liver. Its substrates include bile acids, bromosulphophthalein, and some steroidal compounds. The protein is a member of the SLC21A family of solute carriers. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
670 residues, UniProt reviewed canonical sequence.
>P46721|SLCO1A2
1 MGETEKRIET HRIRCLSKLK MFLLAITCAF VSKTLSGSYM NSMLTQIERQ FNIPTSLVGF
61 INGSFEIGNL LLIIFVSYFG TKLHRPIMIG IGCVVMGLGC FLKSLPHFLM NQYEYESTVS
121 VSGNLSSNSF LCMENGTQIL RPTQDPSECT KEVKSLMWVY VLVGNIVRGM GETPILPLGI
181 SYIEDFAKFE NSPLYIGLVE TGAIIGPLIG LLLASFCANV YVDTGFVNTD DLIITPTDTR
241 WVGAWWFGFL ICAGVNVLTA IPFFFLPNTL PKEGLETNAD IIKNENEDKQ KEEVKKEKYG
301 ITKDFLPFMK SLSCNPIYML FILVSVIQFN AFVNMISFMP KYLEQQYGIS SSDAIFLMGI
361 YNLPPICIGY IIGGLIMKKF KITVKQAAHI GCWLSLLEYL LYFLSFLMTC ENSSVVGINT
421 SYEGIPQDLY VENDIFADCN VDCNCPSKIW DPVCGNNGLS YLSACLAGCE TSIGTGINMV
481 FQNCSCIQTS GNSSAVLGLC DKGPDCSLML QYFLILSAMS SFIYSLAAIP GYMVLLRCMK
541 SEEKSLGVGL HTFCTRVFAG IPAPIYFGAL MDSTCLHWGT LKCGESGACR IYDSTTFRYI
601 YLGLPAALRG SSFVPALIIL ILLRKCHLPG ENASSGTELI ETKVKGKENE CKDIYQKSTV
661 LKDDELKTKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLCO1A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 15 nTPM
- salivary gland: 15 nTPM
- liver: 7.5 nTPM
- choroid plexus: 7 nTPM
- breast: 3.2 nTPM
- lung: 2.5 nTPM
Single-cell type
- oligodendrocytes: 530 nCPM
- retinal pigment epithelial cells: 226 nCPM
- bergmann glia: 42 nCPM
- somatotrophs: 37 nCPM
- vascular endothelial cells: 28 nCPM
- loop of henle epithelial cells: 26 nCPM
Immune cell
- neutrophil: 1.3 nTPM
- MAIT T-cell: 0.6 nTPM
- memory CD4 T-cell: 0.6 nTPM
- naive CD4 T-cell: 0.6 nTPM
- T-reg: 0.6 nTPM
- naive CD8 T-cell: 0.5 nTPM
Brain region
- white matter: 140 nTPM
- basal ganglia: 105 nTPM
- medulla oblongata: 81 nTPM
- pons: 76 nTPM
- midbrain: 75 nTPM
- cerebral cortex: 73 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bile acid and bile salt transport
- monoatomic ion transport
- organic anion transport
- sodium-independent organic anion transport
- xenobiotic metabolic process
Molecular functions
- bile acid transmembrane transporter activity
- organic anion transmembrane transporter activity
- organic cation transmembrane transporter activity
- sodium-independent organic anion transmembrane transporter activity
- transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLCO1A2 as an antibody target. Whether an autoantibody or antibody against SLCO1A2 could matter depends on whether native SLCO1A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLCO1A2 is annotated at the cell surface, where native SLCO1A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLCO1A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...